STSS · Sharps Technology Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $192.8K | - | $83.6K | $222.7K | - | - | - | - | - | - |
| Cost of Revenue | $202.6K | - | $1.25M | $1.25M | - | - | - | - | - | - |
| Gross Profit | ($9.8K) | - | ($1.17M) | ($1.03M) | - | - | - | - | - | - |
| R&D | $137.1K | - | $152.1K | $61.5K | $82.0K | - | $145.6K | $180.3K | $197.4K | - |
| SG&A | $1.36M | - | $110.72M | $1.91M | $1.94M | - | $1.87M | $1.74M | $1.65M | - |
| Total Operating Expenses | $89.39M | - | $103.68M | $1.97M | $2.02M | - | $2.02M | $1.92M | $1.84M | - |
| D&A | $22.3K | - | - | - | $130.9K | - | - | - | $195.4K | - |
| Operating Income | ($86.27M) | - | ($102.64M) | ($3.01M) | ($2.02M) | - | ($2.02M) | ($1.92M) | ($1.84M) | - |
| Interest Expense | - | - | - | $1.00M | - | - | - | - | - | - |
| Income Tax | - | - | - | - | - | - | - | - | - | - |
| Net Income | ($86.24M) | - | ($105.33M) | $3.56M | $1.93M | - | ($1.69M) | ($2.10M) | ($982.4K) | - |
| EPS - Basic | ($1.19) | - | ($4.33) | $3.58 | $38.62 | - | ($381.00) | ($660.00) | ($330.00) | - |
| EPS - Diluted | ($1.19) | - | ($4.33) | $3.58 | $38.62 | - | ($381.00) | ($660.00) | ($330.00) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $12.32M | $10.38M | $10.52M | $8.32M | $11.89M | $864.0K | $2.47M | $1.48M | $1.17M | $3.01M |
| Accounts Receivable | - | - | - | $136.1K | - | - | - | - | - | - |
| Inventory | $457.7K | $645.3K | $745.3K | $1.63M | $2.06M | $1.87M | $2.02M | $1.89M | $1.84M | $1.71M |
| Accounts Payable | $1.58M | $590.7K | $1.83M | $802.2K | $649.5K | $976.5K | $945.6K | $878.0K | $753.8K | $794.1K |
| Current Assets | $18.38M | $18.88M | $39.66M | $10.49M | $14.25M | $3.17M | $4.65M | $3.53M | $3.21M | $4.84M |
| Total Assets | $181.00M | $269.08M | $443.96M | $17.09M | $18.92M | $7.31M | $11.25M | $9.93M | $9.80M | $11.79M |
| Current Liabilities | $2.22M | $4.70M | $10.61M | $2.41M | $8.65M | $5.19M | $4.59M | $2.55M | $2.78M | $3.69M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $2.22M | $4.70M | $10.75M | $2.55M | $8.78M | $5.32M | $4.75M | $2.72M | $2.94M | $3.85M |
| Stockholders' Equity | $178.78M | $264.38M | $433.21M | $14.54M | $5.90M | $2.00M | $6.51M | $7.22M | $6.86M | $7.93M |
| Retained Earnings | ($403.19M) | ($316.95M) | ($134.29M) | ($28.96M) | ($32.52M) | ($34.45M) | ($29.92M) | ($28.23M) | ($26.13M) | ($25.15M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($2.68M) | - | - | - | ($2.45M) | - | - | - | ($1.89M) | - |
| Investing Cash Flow | $9.29M | - | - | - | ($473.7K) | - | - | - | ($2.9K) | - |
| Financing Cash Flow | ($4.67M) | - | - | - | $13.95M | - | - | - | $396 | - |
| CapEx | - | - | - | - | $2.9K | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | ($2.45M) | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | -5.1% | - | -1398.7% | -463.4% | - | - | - | - | - | - |
| Operating margin | -44748.4% | - | -122747.9% | -1349.8% | - | - | - | - | - | - |
| EBITDA margin | -44736.8% | - | - | - | - | - | - | - | - | - |
| Net margin | -44734.5% | - | -125963.6% | 1598.1% | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | -1.27 | - | - | - | - | - |
| R&D / Revenue | 71.1% | - | 181.9% | 27.6% | - | - | - | - | - | - |
| SG&A / Revenue | 707.7% | - | 132404.3% | 858.9% | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -47.6% | - | -23.7% | 20.8% | 10.2% | - | -15.0% | -21.2% | -10.0% | - |
| Return on equity | -48.2% | - | -24.3% | 24.5% | 32.7% | - | -25.9% | -29.1% | -14.3% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 8.28 | 4.02 | 3.74 | 4.35 | 1.65 | 0.61 | 1.01 | 1.38 | 1.15 | 1.31 |
| Quick ratio | 8.08 | 3.88 | 3.67 | 3.67 | 1.41 | 0.25 | 0.57 | 0.64 | 0.49 | 0.85 |
| Cash ratio | 5.55 | 2.21 | 0.99 | 3.45 | 1.38 | 0.17 | 0.54 | 0.58 | 0.42 | 0.82 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | -3.0x | - | - | - | - | - | - |
| Equity multiplier | 1.01 | 1.02 | 1.02 | 1.18 | 3.21 | 3.66 | 1.73 | 1.38 | 1.43 | 1.49 |
| Liabilities / Assets | 0.01 | 0.02 | 0.02 | 0.15 | 0.46 | 0.73 | 0.42 | 0.27 | 0.30 | 0.33 |
| Efficiency | ||||||||||
| Asset turnover | 0.00 | - | 0.00 | 0.01 | - | - | - | - | - | - |
| Inventory turnover | 0.44 | - | 1.68 | 0.77 | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | 223d | - | - | - | - | - | - |
| Days inventory outstanding | 825d | - | 217d | 475d | - | - | - | - | - | - |
| Days payable outstanding | 2849d | - | 532d | 233d | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | 464d | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | 1.5x | 0.2x | - | - | - | - | - |
| P / B | 0.7x | - | 0.4x | 0.4x | 0.1x | - | 202.7x | 4731.4x | 6137.9x | - |
| P / S | 632.4x | - | 1897.9x | 24.4x | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | -4166.9% | - | -4993.5% | -56.5% | -9.6% | - | 14.6% | 24.1% | 20.4% | - |
| Net income growth (YoY) | - | - | -6151.0% | - | - | - | 16.7% | 19.3% | 53.5% | - |
| EPS growth (YoY) | - | - | 98.9% | - | - | - | -224017.6% | -299900.0% | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 2930.2% | 13144.6% | 6559.0% | 101.5% | -14.0% | -74.8% | -38.6% | -16.9% | -37.4% | -17.7% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$204.1K totalMedical Device Packaging$204.1K · 100.0%
Peer comparison
Same SIC group: Surgical & Medical Instruments & Apparatus
Comparing Sharps Technology Inc. against the 5 most active filers in the same SIC group.